GUARDANT HEALTH INC (GH) Stock News
NASDAQ:GH - Nasdaq - US40131M1099 - Common Stock - Currency: USD
GH Latest News, Press Releases and Analysis
Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing.
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
/PRNewswire/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January...
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test
Guardant Reveal test receives expanded Medicare coverage for colorectal cancer recurrence monitoring, enhancing revenue potential and clinical adoption.
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Sheffield United Is Latest Football Club to Agree US Takeover
An American consortium has agreed to buy Sheffield United, one of the biggest English football teams outside the Premier League.
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™
/PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company, today announced that a jury in the U.S. District...
Guardant Health Stock Sees RS Rating Jump To 83
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The rock star money manager is starting to roll with the rallying market.
Why Guardant Health Stock Blasted 13% Higher on Thursday
Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop
The company also hiked its outlook for the year and guided to 20% growth in clinical volumes next year.
Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health Named to TIME’s List of the Best Inventions of 2024
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
Roberto A. Mignone Joins Guardant Health Board of Directors
